It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor tissue penetration and off-target toxicity. These drawbacks can prevent complete ...

Bristol Myers Squibb said it is disappointed with the outcome of a study that examined whether one of its drugs could be used to treat a certain type of skin cancer. The drug, Opdualag, didn't meet ...

University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...

"We have discovered a molecular switch that can revert the fate of cancer cells," said biologist Kwang-Hyun Cho.